BioCorRx Inc. (BICX)
USD 0.43
(-14.0%)
USD 0.43
(-14.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.85 Million | -2.04 Million | -3.53 Million | -2.15 Million | -2.93 Million | -1.82 Million |
| Net Income | -3.76 Million | -4.37 Million | -5.21 Million | -3.5 Million | -6.04 Million | -6.58 Million |
| Depreciation & Amortization | 199.93 Thousand | 141.96 Thousand | 168.94 Thousand | 166.77 Thousand | 96.5 Thousand | 7353.00 |
| Deferred income taxes | -837.75 Thousand | - | 113.25 Thousand | -26 Thousand | 4302.00 | 273.9 Thousand |
| Stock-based compensation | 277.05 Thousand | 354.5 Thousand | 209.51 Thousand | 355.04 Thousand | 1.96 Million | 2.8 Million |
| Change in working capital | 714.26 Thousand | 577.54 Thousand | 703.83 Thousand | 378.16 Thousand | -118.84 Thousand | 127.87 Thousand |
| Other non-cash items | 1.56 Million | 1.26 Million | 477.43 Thousand | 480.65 Thousand | 1.16 Million | 1.54 Million |
| Investing Cash Flow | - | - | -49.99 Thousand | -9227.00 | -121.79 Thousand | -55.94 Thousand |
| Investments in PPE | 2.00 | - | -49.99 Thousand | -9227.00 | -122.59 Thousand | -55.94 Thousand |
| Acquisitions | - | - | - | - | 800.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -47.98 Thousand | -9227.00 | 800.00 | -25.2 Thousand |
| Financing Cash Flow | 1.84 Million | 2.02 Million | 3.08 Million | 107.3 Thousand | 5.42 Million | 2.15 Million |
| Debt repayment | -934.88 Thousand | -450.00 | -831.44 Thousand | -107.3 Thousand | -5.32 Million | -750 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 226 Thousand |
| Common Stock Issuance | 915 Thousand | 1.25 Million | 2.25 Million | - | 100 Thousand | 1.4 Million |
| Other Financing Activities | 934.88 Thousand | 775 Thousand | 1.66 Million | 214.6 Thousand | 5.42 Million | 2.15 Million |
| Accounts receivables | 88.52 Thousand | -33.87 Thousand | -1000.00 | 250.00 | 4850.00 | -2800.00 |
| Accounts payables | 803.11 Thousand | 838.07 Thousand | 698.63 Thousand | 483.77 Thousand | 473.49 Thousand | 385.61 Thousand |
| Inventory | - | - | -698.63 Thousand | -483.77 Thousand | -418.42 Thousand | -33.24 Thousand |
| Other working capital | -177.37 Thousand | -226.64 Thousand | 704.83 Thousand | 377.91 Thousand | -178.76 Thousand | -221.69 Thousand |
| Cash at beginning of period | 68.61 Thousand | 85.83 Thousand | 592.05 Thousand | 2.64 Million | 279.77 Thousand | 11.34 Thousand |
| Cash at end of period | 65.22 Thousand | 68.61 Thousand | 85.83 Thousand | 592.05 Thousand | 2.64 Million | 279.77 Thousand |
| Capital Expenditure | 2.00 | - | -49.99 Thousand | -9227.00 | -122.59 Thousand | -55.94 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3393.00 | -17.22 Thousand | -506.21 Thousand | -2.05 Million | 2.36 Million | 268.43 Thousand |
| Free Cash Flow | -1.85 Million | -2.04 Million | -3.58 Million | -2.16 Million | -3.05 Million | -1.88 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.21 Million | -1.23 Million | -968.54 Thousand | -3.76 Million | -867.34 Thousand | -923.54 Thousand |
| Depreciation & Amortization | 23.33 Thousand | 33.33 Thousand | 86.89 Thousand | 199.93 Thousand | 38.4 Thousand | 37.66 Thousand |
| Deferred income taxes | - | - | -66.23 Thousand | -837.75 Thousand | - | 34.33 Thousand |
| Stock-based compensation | 145.25 Thousand | 198.07 Thousand | 38.26 Thousand | 277.05 Thousand | 81.33 Thousand | 78.24 Thousand |
| Change in working capital | 581.33 Thousand | 371.94 Thousand | 83.14 Thousand | 714.26 Thousand | 247.45 Thousand | 73.39 Thousand |
| Other non-cash items | -119.97 Thousand | 174.93 Thousand | 292.64 Thousand | 1.56 Million | 149.6 Thousand | 128.35 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 59.15 Thousand | 375.52 Thousand | 442.64 Thousand | 1.84 Million | 309.65 Thousand | 565.16 Thousand |
| Debt repayment | -59.15 Thousand | -375.52 Thousand | -427.64 Thousand | -934.88 Thousand | -347.00 | -35.34 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 40.21 Thousand | 15 Thousand | 915 Thousand | - | 600 Thousand |
| Other Financing Activities | 59.51 Thousand | 335.3 Thousand | 443 Thousand | 934.88 Thousand | 310 Thousand | 505.00 |
| Accounts receivables | -88.69 Thousand | 55.96 Thousand | -59.8 Thousand | 88.52 Thousand | 438.00 | -438.00 |
| Accounts payables | 716.13 Thousand | 327.59 Thousand | 205.61 Thousand | 803.11 Thousand | 147.01 Thousand | 206.78 Thousand |
| Inventory | - | - | 353.8 Thousand | - | -147.01 Thousand | -206.78 Thousand |
| Other working capital | -46.1 Thousand | -11.61 Thousand | -62.67 Thousand | -177.37 Thousand | 247.01 Thousand | 73.83 Thousand |
| Cash at beginning of period | 101.08 Thousand | 65.22 Thousand | 156.4 Thousand | 68.61 Thousand | 197.3 Thousand | 203.68 Thousand |
| Cash at end of period | 8365.00 | 101.08 Thousand | 65.22 Thousand | 65.22 Thousand | 156.4 Thousand | 197.3 Thousand |
| Capital Expenditure | 3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -92.71 Thousand | 35.85 Thousand | -91.18 Thousand | -3393.00 | -40.89 Thousand | -6383.00 |
| Free Cash Flow | -151.87 Thousand | -339.66 Thousand | -533.83 Thousand | -1.85 Million | -350.54 Thousand | -571.54 Thousand |
000090
SOJC
6864
GELYY
600106
APGI